FOLH1 and neoplasm: However, when conjugated to PSMA-617 ([177Lu]Lu-HTK01169), Hsiou-Ting Kuo et al. noticed that not only was tumor uptake 8.3-fold higher for [177Lu]Lu-HTK01169 in comparison to [177Lu]Lu-PSMA-617, but also, the absorbed dose in the kidneys was 17.1-fold higher than that of the parent molecule [26].